Allen Lutz
Stock Analyst at Bank of America Securities
(4.71)
# 634
Out of 4,460 analysts
567
Total ratings
64.9%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Downgraded: Sell | $38 → $20 | $20.74 | -3.57% | 42 | Jun 29, 2026 | |
| DH Definitive Healthcare | Downgraded: Sell | $3.5 → $0.7 | $0.8309 | -15.75% | 13 | Jun 29, 2026 | |
| COR Cencora | Maintained: Hold | $280 → $285 | $282.98 | +0.71% | 21 | Jun 24, 2026 | |
| MCK McKesson | Maintained: Buy | $900 | $755.60 | +19.11% | 34 | Jun 24, 2026 | |
| GRDN Guardian Pharmacy Services | Maintained: Buy | n/a | $41.87 | - | 4 | Jun 23, 2026 | |
| CVS CVS Health | Reiterated: Buy | $100 → $110 | $103.45 | +6.33% | 31 | Jun 22, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Buy | $17 | $10.61 | +60.23% | 23 | Jun 11, 2026 | |
| OMCL Omnicell | Maintained: Buy | $70 | $41.52 | +68.59% | 31 | Jun 11, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $28.83 | +7.53% | 22 | Jun 2, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $125 | $90.32 | +38.40% | 55 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $8.48 | +6.13% | 76 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $25 | $34.67 | -27.89% | 70 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $83.52 | - | 22 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $26.35 | +29.03% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $240 | $237.56 | +1.03% | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.53 | - | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 | $3.42 | -34.21% | 16 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.6 → $1.9 | $2.88 | -34.03% | 30 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.12 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $5.74 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
Doximity
Jun 29, 2026
Downgraded: Sell
Price Target: $38 → $20
Current: $20.74
Upside: -3.57%
Definitive Healthcare
Jun 29, 2026
Downgraded: Sell
Price Target: $3.5 → $0.7
Current: $0.8309
Upside: -15.75%
Cencora
Jun 24, 2026
Maintained: Hold
Price Target: $280 → $285
Current: $282.98
Upside: +0.71%
McKesson
Jun 24, 2026
Maintained: Buy
Price Target: $900
Current: $755.60
Upside: +19.11%
Guardian Pharmacy Services
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $41.87
Upside: -
CVS Health
Jun 22, 2026
Reiterated: Buy
Price Target: $100 → $110
Current: $103.45
Upside: +6.33%
DENTSPLY SIRONA
Jun 11, 2026
Maintained: Buy
Price Target: $17
Current: $10.61
Upside: +60.23%
Omnicell
Jun 11, 2026
Maintained: Buy
Price Target: $70
Current: $41.52
Upside: +68.59%
Progyny
Jun 2, 2026
Reiterated: Buy
Price Target: $31
Current: $28.83
Upside: +7.53%
HealthEquity
May 29, 2026
Reiterated: Buy
Price Target: $125
Current: $90.32
Upside: +38.40%
May 28, 2026
Maintained: Buy
Price Target: $9
Current: $8.48
Upside: +6.13%
May 28, 2026
Maintained: Hold
Price Target: $28 → $25
Current: $34.67
Upside: -27.89%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $83.52
Upside: -
May 14, 2026
Maintained: Buy
Price Target: $34
Current: $26.35
Upside: +29.03%
May 13, 2026
Maintained: Buy
Price Target: $240
Current: $237.56
Upside: +1.03%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $20.53
Upside: -
Mar 31, 2026
Reiterated: Sell
Price Target: $2.25
Current: $3.42
Upside: -34.21%
Feb 26, 2026
Reiterated: Sell
Price Target: $2.6 → $1.9
Current: $2.88
Upside: -34.03%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $9.12
Upside: n/a
Jun 20, 2023
Maintained: Hold
Price Target: $12
Current: $5.74
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a